FI905198A0 - Foerfarande foer framstaellning av en stabil polymorf form av (e)-n,n-dietyl-2-cyano-3-(3,4-dihydrox-5-nitro- fenyl) akrylamid. - Google Patents
Foerfarande foer framstaellning av en stabil polymorf form av (e)-n,n-dietyl-2-cyano-3-(3,4-dihydrox-5-nitro- fenyl) akrylamid.Info
- Publication number
- FI905198A0 FI905198A0 FI905198A FI905198A FI905198A0 FI 905198 A0 FI905198 A0 FI 905198A0 FI 905198 A FI905198 A FI 905198A FI 905198 A FI905198 A FI 905198A FI 905198 A0 FI905198 A0 FI 905198A0
- Authority
- FI
- Finland
- Prior art keywords
- acrylamide
- cyano
- diethyl
- stable
- polymorf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8924838A GB2238047B (en) | 1989-11-03 | 1989-11-03 | Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation |
GB8924838 | 1989-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI905198A0 true FI905198A0 (fi) | 1990-10-23 |
FI107149B FI107149B (fi) | 2001-06-15 |
Family
ID=10665678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI905198A FI107149B (fi) | 1989-11-03 | 1990-10-23 | Menetelmä (E)-N,N-dietyyli-2-syano-3-(3,4-dihydroksi-5-nitro-fenyyli)akryyliamidin stabiilin polymorfisen muodon valmistamiseksi |
Country Status (13)
Country | Link |
---|---|
US (1) | US5135950A (fi) |
EP (1) | EP0426468B1 (fi) |
JP (1) | JP2823680B2 (fi) |
AT (1) | ATE127447T1 (fi) |
BR (1) | BR1100289A (fi) |
DE (2) | DE69022166T2 (fi) |
DK (1) | DK0426468T3 (fi) |
ES (1) | ES2075885T3 (fi) |
FI (1) | FI107149B (fi) |
GB (1) | GB2238047B (fi) |
GR (1) | GR3017526T3 (fi) |
LU (1) | LU91071I2 (fi) |
NL (1) | NL300147I1 (fi) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283352A (en) * | 1986-11-28 | 1994-02-01 | Orion-Yhtyma Oy | Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
GB9113431D0 (en) * | 1991-06-20 | 1991-08-07 | Orion Yhytma Oy | Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde |
CA2080554A1 (en) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Styrene derivatives |
JPH05301838A (ja) * | 1991-10-15 | 1993-11-16 | Mitsubishi Kasei Corp | スチレン誘導体 |
US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
BRPI0417799A (pt) * | 2003-12-19 | 2007-04-17 | Hoffmann La Roche | inibidores de comt |
AU2003296838A1 (en) * | 2003-12-24 | 2005-08-11 | Siddiqui Mohammed Jaweed Mukarram | An efficient process for the manufacture of (e)-entacapone polymorphic form a |
WO2005066117A1 (en) * | 2003-12-29 | 2005-07-21 | Wockhardt Limited | Stable polymorphs of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide |
AU2003287844A1 (en) * | 2003-12-31 | 2005-07-21 | Cilag Ag | Novel crystalline forms of entacapone, and production thereof |
US20080076825A1 (en) * | 2003-12-31 | 2008-03-27 | Thomas Bader | Novel Crystalline Forms of Entacapone and Production Thereof |
EP1577289A1 (en) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
AU2005257982B8 (en) * | 2004-06-16 | 2011-03-10 | Jack Arbiser | Carbazole formulations for the treatment of psoriasis and angiogenesis |
EP1812070B1 (en) | 2004-11-10 | 2013-10-02 | Orion Corporation | Treatment of restless legs syndrome |
EA013161B1 (ru) | 2005-06-08 | 2010-02-26 | Орион Корпорейшн | Дозированная форма для перорального применения |
AU2006261893A1 (en) * | 2005-06-23 | 2007-01-04 | Combinatorx, Incorporated | Improved dosage forms for movement disorder treatment |
EP1764093A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
EP1764096A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
EP1945607B1 (en) * | 2005-11-09 | 2009-10-14 | USV Limited | A process for the preparation of highly pure (e) n,n-diethyl-2-cyano-3-(3,4-dihydroxy- 5-nitro phenyl) acrylamide (entacapone) |
US20080300420A1 (en) * | 2006-01-02 | 2008-12-04 | Sanmar Speciality Chemicals Ltd. | Process for the Preparation of Entacapone Form-A |
US7932415B2 (en) * | 2006-02-06 | 2011-04-26 | Orion Corporation | Process for manufacturing entacapone |
WO2007094007A1 (en) * | 2006-02-13 | 2007-08-23 | Suven Life Sciences Ltd., | An improved process for the preparation of entacapone |
WO2007113845A1 (en) * | 2006-04-03 | 2007-10-11 | Alembic Limited | A process for the preparation of (e)-2-cyano-3-(3, 4-dihydroxy-5-nitrophenyl)-n, n-diethyl-2-propenamide (entacapone) |
GB0610207D0 (en) * | 2006-05-23 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | New forms of active pharmaceutical ingredient |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20080004343A1 (en) * | 2006-06-29 | 2008-01-03 | Wockhardt Limited | Stable polymorphs of (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide |
GB0613826D0 (en) * | 2006-07-12 | 2006-08-23 | Pliva Istrazivanje I Razvoj D | Process and product |
ES2306587B1 (es) * | 2006-11-15 | 2009-08-07 | Quimica Sintetica, S.A. | Nueva forma cristalina de entacapona y procedimiento para su obtencion. |
ITMI20062450A1 (it) * | 2006-12-19 | 2008-06-20 | Dipharma Spa | Procedimento per la preparazione di entacapone |
EP2063867A2 (en) * | 2006-12-22 | 2009-06-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
ES2319024B1 (es) * | 2007-02-13 | 2009-12-11 | Quimica Sintetica, S.A. | Procedimiento para la obtencion de entacapona sustancialmente libre de isomero z, sus intermedios de sintesis y nueva forma cristalina. |
WO2009084031A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | An improved process for preparation of (2e)-2-cyano-3-(3,4- dihydroxy-5-nitrophenyl)n,n-diethyl-2-propenamide polymorphic form a |
EP2251323B1 (en) | 2009-05-14 | 2014-04-23 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Method for the purification of entacapone |
EA026419B1 (ru) | 2010-03-04 | 2017-04-28 | Орион Корпорейшн | Применение леводопы, карбидопы и энтакапона для лечения болезни паркинсона |
CN103845317B (zh) | 2012-11-28 | 2018-05-08 | 北京生命科学研究所 | 恩他卡朋在预防或治疗肥胖等代谢综合征中的应用 |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
CA2926082C (en) | 2013-10-07 | 2022-06-14 | Impax Laboratories, Inc. | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
CN104402764A (zh) * | 2014-11-26 | 2015-03-11 | 千辉药业(安徽)有限责任公司 | 一种恩他卡朋的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU213587A (en) * | 1986-11-28 | 1989-06-30 | Orion Yhtymae Oy | Process for obtaining new pharmacologic active cateholic derivatives |
EP0304493B1 (en) * | 1987-03-11 | 1992-09-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hydroxystyrene derivatives |
AU618595B2 (en) * | 1988-04-28 | 1992-01-02 | Suntory Limited | Derivative of caffeic acid and pharmaceutical composition containing the same |
JP2535058B2 (ja) * | 1988-07-29 | 1996-09-18 | 富士通株式会社 | 半導体装置の製造方法 |
-
1989
- 1989-11-03 GB GB8924838A patent/GB2238047B/en not_active Revoked
-
1990
- 1990-10-23 FI FI905198A patent/FI107149B/fi not_active IP Right Cessation
- 1990-10-31 US US07/606,717 patent/US5135950A/en not_active Expired - Lifetime
- 1990-11-01 AT AT90311963T patent/ATE127447T1/de active
- 1990-11-01 DE DE69022166T patent/DE69022166T2/de not_active Expired - Lifetime
- 1990-11-01 ES ES90311963T patent/ES2075885T3/es not_active Expired - Lifetime
- 1990-11-01 DK DK90311963.4T patent/DK0426468T3/da active
- 1990-11-01 EP EP90311963A patent/EP0426468B1/en not_active Expired - Lifetime
- 1990-11-01 DE DE200412000014 patent/DE122004000014I1/de active Pending
- 1990-11-02 JP JP2298708A patent/JP2823680B2/ja not_active Expired - Lifetime
-
1995
- 1995-09-26 GR GR950402644T patent/GR3017526T3/el unknown
-
1997
- 1997-04-15 BR BR1100289-1A patent/BR1100289A/pt active IP Right Grant
-
2004
- 2004-04-09 LU LU91071C patent/LU91071I2/fr unknown
- 2004-04-16 NL NL300147C patent/NL300147I1/nl unknown
Also Published As
Publication number | Publication date |
---|---|
BR1100289A (pt) | 1999-10-05 |
US5135950A (en) | 1992-08-04 |
JP2823680B2 (ja) | 1998-11-11 |
DE69022166D1 (de) | 1995-10-12 |
FI107149B (fi) | 2001-06-15 |
GB8924838D0 (en) | 1989-12-20 |
DK0426468T3 (da) | 1995-10-23 |
ES2075885T3 (es) | 1995-10-16 |
GB2238047A (en) | 1991-05-22 |
JPH03169844A (ja) | 1991-07-23 |
ATE127447T1 (de) | 1995-09-15 |
DE69022166T2 (de) | 1996-02-15 |
LU91071I2 (fr) | 2005-06-21 |
DE122004000014I1 (de) | 2004-08-12 |
GR3017526T3 (en) | 1995-12-31 |
GB2238047B (en) | 1993-02-10 |
NL300147I1 (nl) | 2004-07-01 |
EP0426468B1 (en) | 1995-09-06 |
EP0426468A3 (en) | 1992-05-06 |
EP0426468A2 (en) | 1991-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI905198A0 (fi) | Foerfarande foer framstaellning av en stabil polymorf form av (e)-n,n-dietyl-2-cyano-3-(3,4-dihydrox-5-nitro- fenyl) akrylamid. | |
FR2710638B1 (fr) | Procédé de préparation d'isomères d'acides benzènedicarboxyliques de haute pureté. | |
DE69120500T2 (de) | Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung | |
DE69001187D1 (de) | 6-epifumagillole, ihre herstellung und ihre verwendung. | |
DE69311837D1 (de) | Steroide zur Behandlung von Prostatisch-Hypertrophe, ihre Herstellung und Verwendung | |
EP0778262A3 (en) | Process for the purification of (RR-SS)-2-dimethyl-aminomethyl-1-(3-methoxyphenyl)cyclohexanol and its salts | |
NO175529C (no) | Fremgangsmåte for rensing av tryptofan | |
DE69517201D1 (de) | Verfahren zur herstellung von 2-(2-hydroxymethylphenyl)acetamid-derivaten und zwischenprodukte zur herstellung | |
JPS6425750A (en) | Manufacture of 3,3-diarylacrylic acid amide | |
EA199700391A1 (ru) | Способ получения производных карбоновых кислот | |
HUT45006A (en) | Process for producing 4-halogeno-2-/oxy-imino/-3-oxo-butiric acid derivatives | |
DE59902731D1 (de) | Verfahren zur Herstellung von höheren ungesättigten Ketonen | |
DK680487D0 (da) | I det vaesentlige vandfrit, krystallinsk cefadroxil og fremgangsmaade til fremstilling deraf | |
DE69028938D1 (de) | Verfahren zur Reinigung von 3-alpha-7-beta-Dihydroxycholansäure | |
DE69225651D1 (de) | Verwendung von halogenierten beta-lactamen zur herstellung von 3-hydroxycephem-derivaten | |
JPS57120572A (en) | Guanidine derivative and its preparation | |
CA2200607A1 (en) | Processes and intermediates for preparing 5,7-dihydro-3-[2-{1-benzylpiperidin-4-yl}ethyl]-6h-pyrrolo-[4,5-f]-1,2-benzisoxazol-6-one | |
ATE66453T1 (de) | Herstellung von zwischenverbindungen fuer leukotrien-antagonisten. | |
ES8205193A1 (es) | Procedimiento para la obtencion de sales de acidos alcancar-boxilicos | |
JPS57120573A (en) | Production of guanidine derivative | |
JPS5777662A (en) | 3-substituted 2-propenenitrile derivative and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20020006 |
|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20040007 |
|
FG | Patent granted |
Owner name: ORION-YHTYMAE OY |
|
PC | Transfer of assignment of patent |
Owner name: ORION CORPORATION Free format text: ORION CORPORATION |
|
SPCG | Supplementary protection certificate granted |
Spc suppl protection certif: 221 Extension date: 20151023 |
|
SPCR | Lapse or expiry of a supplementary protection certificate |
Spc suppl protection certif: 221 Effective date: 20140311 |